Dean Crowe, Founder and CEO of the Rally Foundation for Childhood Cancer Research, shared a post on LinkedIn:
“The mRNA COVID vaccines that divided a nation may now be pointing toward something entirely different: new ways to treat cancer, including in children.
In this op-ed for the Atlanta Journal-Constitution, I focus on why decisions about infectious disease policy should not slow progress in mRNA cancer and rare-disease research, just as the science is showing real promise.
A recent Nature Magazine study suggests that mRNA vaccines, when paired with cancer immunotherapy, may significantly improve survival in some cancers. That signal deserves serious attention.
Every day in America, 47 children are diagnosed with cancer. Many are still treated with drugs developed decades ago. If mRNA technology can help today’s most advanced cancer therapies work better, we owe it to kids and everyone fighting cancer to follow the science wherever it leads.”
Did you know that Dean Crowe has been Recognized Among The 100 Most Influential CEOs in Oncology in 2025? Read more.
